P552-02 (mesylate)
P552-02 (552-02) mesylate is a sodium channel blocker that is potentially used for the treatment of cystic fibrosis, exhibiting biological activity that enhances mucociliary clearance in the lungs while minimizing the risk of hyperkalaemia.
Product Specifications
CAS Number
[587879-54-7]
Product Name Alternative
552-02
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/p552-02-mesylate.html
Smiles
O=C(C1=NC(Cl)=C(N)N=C1N)NC(NCCCCC2=CC=C(C=C2)OCC(CO)O)=N.O=S(O)(C)=O
Molecular Formula
C20H30ClN7O7S
Molecular Weight
548.01
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items